A. Wollenberg, E. Guttman-Yassky, M. Torpet, and J. I. Silverberg, “Risk of anaphylaxis and conjunctivitis with tralokinumab in atopic dermatitis”, J of Skin, vol. 2, p. S63, Dec. 2018.